Distinct toll-like receptor 3 and 7 expression in peripheral blood mononuclear cells from patients with chronic hepatitis C infection

Hepatitis Monthly

Volumn 14, Issue 4, 2014, Pages

  Motavaf, Mahsa ^a,b   Noorbakhsh, Fatemeh ^a   Alavian, Seyed Moayed ^b   Sharifi, Zohreh ^a,c  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b Middle East Liver Diseases Center (MELD Centers)   (Iran)

^c HIGH INSTITUTE FOR RESEARCH AND EDUCATION IN TRANSFUSION MEDICINE   (Iran)

Author keywords

Chronic; Gene expression; Hepatitis C; Immunity; Innate; Toll like receptor 3; Toll like receptor 7

Indexed keywords

TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HUMAN; MALE; MIDDLE AGED; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; RANK SUM TEST; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION;

EID: 84898844083     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.16421     Document Type: Article

References (21)

1. Alavian S, Asl M, Lankarani K, Shahbabaie M, Bahrami Ahmadi A, Kabir A. Hepatitis C Infection in the General Population of Iran: A Systematic Review. Hepat Mon. 2009; 9(3): 211-23.
2. Vaidya SA, Cheng G. Toll-like receptors and innate antiviral responses. Curr Opin Immunol. 2003; 15(4): 402-7.
3. Mozer-Lisewska I, Sikora J, Kowala-Piaskowska A, Kaczmarek M, Dworacki G, Żeromski J. The incidence and significance of pattern-recognition receptors in chronic viral hepatitis types B and C in man. 2010; 58(4): 295-302.
4. Akira S, Takeda K. Toll-like receptor signalling. Nature Rev Immunol. 2004; 4(7): 499-511.
5. Schulz O, Diebold SS, Chen M, Naslund TI, Nolte MA, Alexopoulou L, et al. Toll-like receptor 3 promotes cross-priming to virusinfected cells. Nature. 2005; 433(7028): 887-92.
6. Duong FHT, Filipowicz M, Tripodi M, La Monica N, Heim MH. Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A. Gastroenterol. 2004; 126(1): 263-77.
7. Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, Ikeda M, et al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A. 2005; 102(8): 2992-7.
8. Sumpter R, Jr., Loo YM, Foy E, Li K, Yoneyama M, Fujita T, et al. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol. 2005; 79(5): 2689-99.
9. Atencia R, Bustamante FJ, Valdivieso A, Arrieta A, Rinon M, Prada A, et al. Differential expression of viral PAMP receptors mRNA in peripheral blood of patients with chronic hepatitis C infection. BMC Infect Dis. 2007; 7: 136.
10. Chang S, Kodys K, Szabo G. Impaired expression and function of toll-like receptor 7 in hepatitis C virus infection in human hepatoma cells. Hepatology. 2010; 51(1): 35-42.
11. Vollmer J, Rankin R, Hartmann H, Jurk M, Samulowitz U, Wader T, et al. Immunopharmacology of CpG oligodeoxynucleotides and ribavirin. Antimicrob Agents Chemother. 2004; 48(6): 2314-7.
12. Dolganiuc A, Garcia C, Kodys K, Szabo G. Distinct Toll-like receptor expression in monocytes and T cells in chronic HCV infection. World J Gastroenterol. 2006; 12(8): 1198-204.
13. Lehmann MH, Weber J, Gastmann O, Sigusch HH. Pseudogenefree amplification of human GAPDH cDNA. Biotechniques. 2002; 33(4): 766-70.
14. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001; 29(9): e45.
15. Pflugheber J, Fredericksen B, Sumpter R, Jr., Wang C, Ware F, Sodora DL, et al. Regulation of PKR and IRF-1 during hepatitis C virus RNA replication. Proc Natl Acad Sci U S A. 2002; 99(7): 4650-5.
16. Abe T, Kaname Y, Hamamoto I, Tsuda Y, Wen X, Taguwa S, et al. Hepatitis C virus nonstructural protein 5A modulates the tolllike receptor-MyD88-dependent signaling pathway in macrophage cell lines. J Virol. 2007; 81(17): 8953-66.
17. Thomas A, Laxton C, Rodman J, Myangar N, Horscroft N, Parkinson T. Investigating Toll-like receptor agonists for potential to treat hepatitis C virus infection. Antimicrob Agents Chemother. 2007; 51(8): 2969-78.
18. Imran M, Waheed Y, Manzoor S, Bilal M, Ashraf W, Ali M, et al. Interaction of Hepatitis C virus proteins with pattern recognition receptors. Virol J. 2012; 9: 126.
19. Mohammed KI, Adel LA, Ali-Eldin FA, Eladawy S. Expression of Toll like receptors 3 & 7 in peripheral blood from patients with chronic hepatitis C virus infection and their correlation with interferon-alpha. Egypt J Immunol. 2013; 20(1): 13-22.
20. Sato K, Ishikawa T, Okumura A, Yamauchi T, Sato S, Ayada M, et al. Expression of Toll-like receptors in chronic hepatitis C virus infection. J Gastroenterol Hepatol. 2007; 22(10): 1627-32.
21. Lee J, Wu CC, Lee KJ, Chuang TH, Katakura K, Liu YT, et al. Activation of anti-hepatitis C virus responses via Toll-like receptor 7. Proc Natl Acad Sci U S A. 2006; 103(6): 1828-33.